CLChao Li

Chao Li

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Chao Li has a total of 18 co-authors. Here are the top co-authors by number of shared publications:

  • Chao Shi

    The First Affiliated Hospital of Bengbu Medical College

    1 shared publication
  • Feng-He Li

    School of Pharmacy (Anhui Medical University) Inflammation and Immune Mediated Diseases Laboratory of Anhui Province Key Laboratory of Anti‐Inflammatory and Immune Medicine (Anhui Medical University) Ministry of Education Anhui Institute of Innovative Drugs Anhui Medical University Hefei China

    1 shared publication
  • Hongyan Wang

    State Key Laboratory of Tea Plant Germplasm Innovation and Resource Utilization, School of Food and Nutrition, Joint Research Center for Food Nutrition and Health of IHM, Anhui Agricultural University, Hefei, Anhui 230036, China; Anhui Provincial Key Laboratory of Food Safety Monitoring and Quality Control, Anhui Agricultural University, Hefei, Anhui 230036, China

    1 shared publication
  • Jia-Gen Wen

    Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, the, Ministry of Education, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei, China

    1 shared publication
  • Jing Wang

    Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei 230032, China

    1 shared publication
  • Juan Jin

    Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, the, Ministry of Education, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei, China

    1 shared publication

Latest Publications

  • Open Access

    A novel GSK3β inhibitor 5n attenuates acute kidney injury

    by Yu-Ting Cai, Zeng Li, Yue-Yue Wang, Chao Li, Qiu-Ying Ma


  • Open Access

    Epigallocatechin Gallate Attenuates Gentamicin-Induced Nephrotoxicity by Suppressing Apoptosis and Ferroptosis

    by Lin Yue, Ya-Ru Yang, Wen-Xian Ma, Hong-Yan Wang, Qian-Wen Fan, Yue-Yue Wang, Chao Li, Jing Wang, Zi-Mu Hu, Xue-Fu Wang, et al.

    Gentamicin (GEN) is a kind of aminoglycoside antibiotic with the adverse effect of nephrotoxicity. Currently, no effective measures against the nephrotoxicity have been approved. In the present study, epigallocatechin gallate (EG), a useful ingredient in green tea, was used to attenuate its nephrotoxicity. EG was shown to largely attenuate the renal damage and the increase of malondialdehyde (MDA) and the decrease of glutathione (GSH) in GEN-injected rats. In NRK-52E cells, GEN increased the cellular ROS in the early treatment phase and ROS remained continuously high from 1.5 H to 24 H. Moreover, EG alleviated the increase of ROS and MDA and the decrease of GSH caused by GEN. Furthermore, EG activated the protein levels of nuclear factor erythroid 2-related factor 2 (Nrf2) and heme oxygenase-1 (HO-1). After the treatment of GEN, the protein level of cleaved-caspase-3, the flow cytometry analysis and the JC-1 staining, the protein levels of glutathione peroxidase 4 (GPX4) and SLC7A11, were greatly changed, indicating the occurrence of both apoptosis and ferroptosis, whereas EG can reduce these changes. However, when Nrf2 was knocked down by siRNA, the above protective effects of EG were weakened. In summary, EG attenuated GEN-induced nephrotoxicity by suppressing apoptosis and ferroptosis.